skip to Main Content

Podcasts

Rest your eyes or use your commute time to learn. Listen to our experts discuss the hot topics that you need to track. And get a glimpse into the personalities behind the smiles.

Avalere’s Take on CJR

Are bundled payments fundamentally changing the way care is provided? Listen in as Fred Bentley, Avalere Center & Payment Delivery Innovation, explains how bundled payment models are spurring clinical innovation and the creation of cross-continuum partnerships.

FDA Efforts in Patient Engagement

In recent years, stakeholders have increasingly become aware of the potential opportunities surrounding incorporation of the patient perspective into early stages of drug development. Listen to Debleena Sengupta discuss how patient input is evaluated and incorporated into the FDA's decision-making process.

Growing Patient Access to Electronic Health Data

To what extent do patients currently have access to their own data in their providers’ electronic health records, and what does the future hold for consumer access to their digital health data? Listen to Avalere's Josh Seidman share how far we’ve come with providing patients access to their health data, where there is still room for improvement, and what patients can expect to see in the future.

Quality Measurement in the Era of MACRA

While Medicare Access and CHIP Reauthorization Act or MACRA seeks to stabilize Medicare and assure physicians a predictable stream of revenue given a schedule of expected physician payment updates, how can providers leverage MACRA to improve quality of care? Listen in as Kristi Mitchell suggests how providers can use MACRA as a springboard to develop and implement relevant quality measures to close the current measurement gaps across disease conditions and care settings.

ACA Provisions Address Quality Reporting Requirements

The ACA is built on a foundation of improving the quality of care for all patients and includes a number of provisions to help consumers make decisions about where to receive their care as well as how to increase the transparency of services through value-based purchasing efforts and private sector programs. Listen in as Nelly Ganesan discusses the trend of using value-based systems in quality reporting programs which will require physicians to focus on outcomes versus processes.

Compassionate Use

When life sciences companies consider whether to allow compassionate use—access to unapproved investigational treatments outside of clinical trials—there are no easy answers. Brenda Huneycutt gleans insight from Arthur Caplan, PhD, and Alison Bateman-House, PhD, from the New York University Langone Medical Center Division of Medical Ethics on some of the many questions that life sciences companies should ask themselves before implementing a compassionate use policy.

The Time is Now for ACOs

With something as complex and as political as shared savings models in healthcare, there will always be push-back. But according to Avalere’s Josh Seidman, now is a unique opportunity for ACOs to finally succeed. Josh explains that the current healthcare infrastructure makes ACOs attainable thanks to recent changes, including increased electronic health record use, more provider comfort with comparative performance reporting, enhanced centrality of patient engagement and new incentives that reward accountability and value.

Quality Measurement Is the Foundation for Improving Quality Care

The use of quality and performance measures in public reporting, value-based purchasing, and alternative payment models is altering clinical practice by providing incentives to improve quality measures performance and provide high-value care. Debbie Lucas helps many stakeholders seek to understand these measures, assess their business impacts, and use the information to guide decision-making.

What’s to Come in MolDx?

Meet Kathy Hughes who leads our Molecular Diagnostics team and has successfully advised device, diagnostics and pharmaceutical companies on optimal market access strategies for over a decade. Kathy addresses key evidentiary developments in the diagnostics space, and what she sees as the future of this evolving field.

Benchmark Survey Results

A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.

Back To Top